Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-006790
Filing Date
2022-05-03
Accepted
2022-05-03 15:27:38
Documents
52
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rytm-20220331x10q.htm   iXBRL 10-Q 1475817
2 EX-31.1 rytm-20220331xex31d1.htm EX-31.1 12982
3 EX-31.2 rytm-20220331xex31d2.htm EX-31.2 14724
4 EX-32.1 rytm-20220331xex32d1.htm EX-32.1 6980
5 EX-32.2 rytm-20220331xex32d2.htm EX-32.2 7938
  Complete submission text file 0001558370-22-006790.txt   4892434

Data Files

Seq Description Document Type Size
6 EX-101.SCH rytm-20220331.xsd EX-101.SCH 28114
7 EX-101.CAL rytm-20220331_cal.xml EX-101.CAL 48734
8 EX-101.DEF rytm-20220331_def.xml EX-101.DEF 94713
9 EX-101.LAB rytm-20220331_lab.xml EX-101.LAB 294901
10 EX-101.PRE rytm-20220331_pre.xml EX-101.PRE 205113
46 EXTRACTED XBRL INSTANCE DOCUMENT rytm-20220331x10q_htm.xml XML 672294
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38223 | Film No.: 22886419
SIC: 2834 Pharmaceutical Preparations